Target intelligence / Profile preview

Nidogen-2 (NID2)

Target
NID2
Molecular classification
Other (basement membrane glycoprotein), Cell adhesion protein
01

Overview

Nidogen-2 (NID2), also known as osteonidogen, is a highly conserved extracellular matrix glycoprotein and a key structural component of the basement membrane[1][2][4]. It functions primarily as a linker protein, bridging the laminin and collagen IV networks, thus stabilizing the basement membrane and contributing to the maintenance of tissue architecture during development and adult tissue homeostasis[1][2]. Nidogen-2 plays a critical cell-adhesion role by binding to collagens I and IV, laminin, and perlecan[5][2]. Although not strictly required for basement membrane formation or maintenance—as loss of NID2 can be compensated by nidogen-1—it is enriched particularly in the endothelial basement membranes and elastic fibers[1]. NID2 also modulates angiogenesis, vascular remodeling, and influences differentiation in chondrogenic progenitor cells[2][3]. Epigenetic silencing (e.g., promoter hypermethylation) of NID2 is commonly observed in several human cancers, correlating with increased tumor cell proliferation, invasion, and poor prognosis; its methylation status is being explored as a sensitive cancer biomarker in bodily fluids[2].

Other names
Nidogen 2NID2NID-2Osteonidogenosteonidogennidogen-2
02

Biological functions

Basement membrane stabilizationCell adhesionExtracellular matrix organizationModulation of angiogenesisRegulation of cell differentiation
03

Disease associations

Cancer (especially in tumor suppression and metastasis)Potential biomarker for cancer diagnosis (e.g., in oral, bladder, lung, gastric, nasopharyngeal carcinoma, glioma)Musculoskeletal and cartilage (e.g., osteoarthritis)Potential role in vascular remodeling
04

Biomarkers

Aberrant methylation of NID2 (as a diagnostic biomarker for various cancers: oral, bladder, lung, gastric, nasopharyngeal, glioma)

Beyond the preview

Go deeper on Nidogen-2 (NID2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nidogen-2 (NID2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call